Selected research
Industry Research
Eszopiclone Industry Research Report 2026
Market perspective
The global Eszopiclone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Eszopiclone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Eszopiclone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Eszopiclone include Tasly Pharmaceutical, Sun Pharmaceutical, Kanghong Pharmaceutical, Wockhardt, Tapi Teva, Shanghai Pharmaceuticals Holding, Kanghong Pharmaceutical, Glenmark Life Sciences and Dr. Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Eszopiclone market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Eszopiclone Market by Company
Tasly Pharmaceutical
Sun Pharmaceutical
Kanghong Pharmaceutical
Wockhardt
Tapi Teva
Shanghai Pharmaceuticals Holding
Kanghong Pharmaceutical
Glenmark Life Sciences
Dr. Reddy’s Laboratories
Centaur Pharmaceuticals
Admiron Life
Eszopiclone Segment by Type
Purity Above 98%
Purity Below 98%
Eszopiclone Segment by Application
Tablet
Capsule
Other
Eszopiclone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Eszopiclone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Eszopiclone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Eszopiclone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Tasly Pharmaceutical
- Sun Pharmaceutical
- Kanghong Pharmaceutical
- Wockhardt
- Tapi Teva
- Shanghai Pharmaceuticals Holding
- Kanghong Pharmaceutical
- Glenmark Life Sciences
- Dr. Reddy’s Laboratories
- Centaur Pharmaceuticals
- Admiron Life
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Eszopiclone Market Size (2021-2032)
- 2.2.2 Global Eszopiclone Sales (2021-2032)
- 2.2.3 Global Eszopiclone Market Average Price (2021-2032)
- 2.3 Eszopiclone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity Above 98%
- 2.3.3 Purity Below 98%
- 2.4 Eszopiclone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet
- 2.4.3 Capsule
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Eszopiclone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Eszopiclone Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Eszopiclone Revenue of Manufacturers (2021-2026)
- 3.4 Global Eszopiclone Average Price by Manufacturers (2021-2026)
- 3.5 Global Eszopiclone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Eszopiclone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Eszopiclone, Product Type & Application
- 3.8 Global Manufacturers of Eszopiclone, Established Date
- 3.9 Global Eszopiclone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tasly Pharmaceutical
- 4.1.1 Tasly Pharmaceutical Company Information
- 4.1.2 Tasly Pharmaceutical Business Overview
- 4.1.3 Tasly Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tasly Pharmaceutical Eszopiclone Product Portfolio
- 4.1.5 Tasly Pharmaceutical Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Eszopiclone Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Kanghong Pharmaceutical
- 4.3.1 Kanghong Pharmaceutical Company Information
- 4.3.2 Kanghong Pharmaceutical Business Overview
- 4.3.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 4.3.5 Kanghong Pharmaceutical Recent Developments
- 4.4 Wockhardt
- 4.4.1 Wockhardt Company Information
- 4.4.2 Wockhardt Business Overview
- 4.4.3 Wockhardt Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wockhardt Eszopiclone Product Portfolio
- 4.4.5 Wockhardt Recent Developments
- 4.5 Tapi Teva
- 4.5.1 Tapi Teva Company Information
- 4.5.2 Tapi Teva Business Overview
- 4.5.3 Tapi Teva Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tapi Teva Eszopiclone Product Portfolio
- 4.5.5 Tapi Teva Recent Developments
- 4.6 Shanghai Pharmaceuticals Holding
- 4.6.1 Shanghai Pharmaceuticals Holding Company Information
- 4.6.2 Shanghai Pharmaceuticals Holding Business Overview
- 4.6.3 Shanghai Pharmaceuticals Holding Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai Pharmaceuticals Holding Eszopiclone Product Portfolio
- 4.6.5 Shanghai Pharmaceuticals Holding Recent Developments
- 4.7 Kanghong Pharmaceutical
- 4.7.1 Kanghong Pharmaceutical Company Information
- 4.7.2 Kanghong Pharmaceutical Business Overview
- 4.7.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 4.7.5 Kanghong Pharmaceutical Recent Developments
- 4.8 Glenmark Life Sciences
- 4.8.1 Glenmark Life Sciences Company Information
- 4.8.2 Glenmark Life Sciences Business Overview
- 4.8.3 Glenmark Life Sciences Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Glenmark Life Sciences Eszopiclone Product Portfolio
- 4.8.5 Glenmark Life Sciences Recent Developments
- 4.9 Dr. Reddy’s Laboratories
- 4.9.1 Dr. Reddy’s Laboratories Company Information
- 4.9.2 Dr. Reddy’s Laboratories Business Overview
- 4.9.3 Dr. Reddy’s Laboratories Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy’s Laboratories Eszopiclone Product Portfolio
- 4.9.5 Dr. Reddy’s Laboratories Recent Developments
- 4.10 Centaur Pharmaceuticals
- 4.10.1 Centaur Pharmaceuticals Company Information
- 4.10.2 Centaur Pharmaceuticals Business Overview
- 4.10.3 Centaur Pharmaceuticals Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Centaur Pharmaceuticals Eszopiclone Product Portfolio
- 4.10.5 Centaur Pharmaceuticals Recent Developments
- 4.11 Admiron Life
- 4.11.1 Admiron Life Company Information
- 4.11.2 Admiron Life Business Overview
- 4.11.3 Admiron Life Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Admiron Life Eszopiclone Product Portfolio
- 4.11.5 Admiron Life Recent Developments
5 Global Eszopiclone Market Scenario by Region
- 5.1 Global Eszopiclone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Eszopiclone Sales by Region: 2021-2032
- 5.2.1 Global Eszopiclone Sales by Region: 2021-2026
- 5.2.2 Global Eszopiclone Sales by Region: 2027-2032
- 5.3 Global Eszopiclone Revenue by Region: 2021-2032
- 5.3.1 Global Eszopiclone Revenue by Region: 2021-2026
- 5.3.2 Global Eszopiclone Revenue by Region: 2027-2032
- 5.4 North America Eszopiclone Market Facts & Figures by Country
- 5.4.1 North America Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Eszopiclone Sales by Country (2021-2032)
- 5.4.3 North America Eszopiclone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Eszopiclone Market Facts & Figures by Country
- 5.5.1 Europe Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Eszopiclone Sales by Country (2021-2032)
- 5.5.3 Europe Eszopiclone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Eszopiclone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Eszopiclone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Eszopiclone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Eszopiclone Market Facts & Figures by Country
- 5.7.1 South America Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Eszopiclone Sales by Country (2021-2032)
- 5.7.3 South America Eszopiclone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Eszopiclone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Eszopiclone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Eszopiclone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Eszopiclone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Eszopiclone Sales by Type (2021-2032)
- 6.1.1 Global Eszopiclone Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Eszopiclone Sales Market Share by Type (2021-2032)
- 6.2 Global Eszopiclone Revenue by Type (2021-2032)
- 6.2.1 Global Eszopiclone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Eszopiclone Revenue Market Share by Type (2021-2032)
- 6.3 Global Eszopiclone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Eszopiclone Sales by Application (2021-2032)
- 7.1.1 Global Eszopiclone Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Eszopiclone Sales Market Share by Application (2021-2032)
- 7.2 Global Eszopiclone Revenue by Application (2021-2032)
- 7.2.1 Global Eszopiclone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Eszopiclone Revenue Market Share by Application (2021-2032)
- 7.3 Global Eszopiclone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Eszopiclone Value Chain Analysis
- 8.1.1 Eszopiclone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Eszopiclone Production Mode & Process
- 8.2 Eszopiclone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Eszopiclone Distributors
- 8.2.3 Eszopiclone Customers
9 Global Eszopiclone Analyzing Market Dynamics
- 9.1 Eszopiclone Industry Trends
- 9.2 Eszopiclone Industry Drivers
- 9.3 Eszopiclone Industry Opportunities and Challenges
- 9.4 Eszopiclone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst